Literature DB >> 9714182

Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages.

W Weninger1, M Rendl, J Pammer, M Mildner, W Tschugguel, C Schneeberger, M Stürzl, E Tschachler.   

Abstract

Kaposi's sarcoma (KS) is a tumor of presumed vascular origin frequently found in patients with AIDS. Recent data suggest that the development of KS is linked with the presence of a newly recognized herpesvirus, human herpesvirus type 8. Nitric oxide (NO), a messenger molecule with vasoactive, antitumor, and antimicrobial effects, is produced by three isoforms of nitric oxide synthases (NOS). In the present report, we investigated the expression of NOS isoforms in KS. By NADPH-diaphorase histochemistry, NOS activity was detectable in endothelia and CD45+ cells within KS lesions. Reactivity for endothelial NOS (eNOS) was found in blood vessel endothelia; however, eNOS reactivity was negative in KS spindle cells in 12 of 17 tumors, and moderately positive in the other 5 lesions. In contrast to KS, tumor cells in three hemangiomas and one angiosarcoma were strongly positive for eNOS. Inducible NOS (iNOS) was absent from KS tumor cells but was found regularly in CD45+, HLA-DR+ cells within the lesions. In five KS-derived spindle cell cultures, neither eNOS nor iNOS proteins were detectable. The sporadic expression of eNOS by KS spindle cells in vivo and the absence of eNOS protein from KS spindle cells in tissue cultures argue against the possibility that the cells are derived from blood vessel endothelia. The consistent expression of iNOS by CD45+, HLA-DR+ cells within KS lesions strongly suggests that leukocyte-derived NO participates in the pathology of this tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714182

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

Review 1.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

Review 2.  Signaling and stress: The redox landscape in NOS2 biology.

Authors:  Douglas D Thomas; Julie L Heinecke; Lisa A Ridnour; Robert Y Cheng; Aparna H Kesarwala; Christopher H Switzer; Daniel W McVicar; David D Roberts; Sharon Glynn; Jon M Fukuto; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-06-24       Impact factor: 7.376

3.  Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.

Authors:  G M K Tse; F C Wong; A K H Tsang; C S Lee; P C W Lui; A W I Lo; B K B Law; R A Scolyer; R Z Karim; T C Putti
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

4.  Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.

Authors:  Debashree Basudhar; Robert C Cheng; Gaurav Bharadwaj; Lisa A Ridnour; David A Wink; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2015-02-04       Impact factor: 7.376

5.  Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.

Authors:  Zhiqiang Qin; Eduardo Freitas; Roger Sullivan; Sarumathi Mohan; Rocky Bacelieri; Drake Branch; Margaret Romano; Patricia Kearney; Jim Oates; Karlie Plaisance; Rolf Renne; Johnan Kaleeba; Chris Parsons
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

6.  Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.

Authors:  Gabor Oláh; Katalin Módis; Gabor Törö; Mark R Hellmich; Bartosz Szczesny; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-10-23       Impact factor: 5.858

7.  Plasma Metabolomics Analysis of Polyvinyl Chloride Workers Identifies Altered Processes and Candidate Biomarkers for Hepatic Hemangiosarcoma and Its Development.

Authors:  John J Guardiola; Josiah E Hardesty; Juliane I Beier; Russell A Prough; Craig J McClain; Matthew C Cave
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.